Neglected Diseases and Drug Discovery

12 Jan 2012
RSC Drug Discovery

DOI:10.1039/9781849733496

An edited volume published by the Royal Society of Chemistry, co-edited by MMV’s CSO, Tim Wells. Chapter 5 is co-authored by Jeremy Burrows.

This volume, published by the Royal Society of Chemistry and co-edited by MMV’s Tim Wells, presents a state-of-the-art review of drug discovery for neglected tropical diseases (NTDs). Around 8 million people die every year from these diseases, while drug discovery in this area is only just beginning to take on greater urgency and embrace the latest technologies.

This book highlights best practice for ongoing drug discovery and aims to raise awareness about NTDs, so they do not remain ‘neglected’.

Neglected Diseases and Drug Discovery makes a critical appraisal of ongoing research with a focus on the key science that has led to breakthroughs, especially from a medicinal chemistry perspective. It covers, in great depth, current efforts in the fields of malaria, trypanosomatid, flavivirus and tuberculosis. Additionally, it focuses on the most neglected diseases, notably diarrhea, helminths, HIV and lower respiratory tract infections.

Written by a team of experienced experts the book will prove to be an invaluable guide to successful drug discovery practice in neglected tropical diseases. It will aid both researchers and the general reader by summarising key learnings to date and providing a clear overview of the challenges that still remain.

 


 

This book can be purchased on the RSC website. RSC subscribers can view the book by chapter online.